Abstract
Background Decision-making alterations are present in psychiatric illnesses like major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and schizophrenia, linked to symptoms of the respective disorders. Understanding unique and shared decision-making alterations across these disorders is crucial for early diagnosis and treatment, especially given potential comorbidities.
Methods Using two computational modeling approaches – logistic regression and hierarchical Bayesian modeling – we analyzed alterations in model-based and model-free decision-making in a transdiagnostic cohort comprising MDD (N=23), OCD (N=25), and schizophrenia (N=27) patients. Our aim was to identify disorder-specific and shared alterations and their associations with symptoms.
Results Overall, participants of all groups relied on model-free decision-making. Our results revealed that schizophrenia patients had the lowest learning rate and highest switching rate, indicating low perseverance. Further, OCD patients were more random in both task stages compared to controls and MDD patients. All patient groups exhibited more randomness in responses than controls, with schizophrenia patients showing the highest levels. Importantly, the study showed that increased model-free behavior correlated with elevated depressive symptoms and more model-based decision making was linked to lower anhedonia levels across all patients.
Conclusions This study highlights disorder-specific and shared decision-making alterations in individuals with MDD, OCD, and schizophrenia. This study suggests that anhedonia and depressive symptoms, which are present in all three disorders, share underlying behavioral mechanisms. Improving model-based behavior may which may be a target for intervention and treatment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Technical University of Munich gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
In this revision, the text has been shortened and generally revised. A new title has been provided and power analysis has been added.
Data Availability
The data for this study is available upon reasonable request to the corresponding author.